{"name":"Icagen","slug":"icagen","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"High dose ICA-17043","genericName":"High dose ICA-17043","slug":"high-dose-ica-17043","indication":"Other","status":"phase_2"},{"name":"Low Dose ICA-17043","genericName":"Low Dose ICA-17043","slug":"low-dose-ica-17043","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"High dose ICA-17043","genericName":"High dose ICA-17043","slug":"high-dose-ica-17043","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Low Dose ICA-17043","genericName":"Low Dose ICA-17043","slug":"low-dose-ica-17043","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPQzFoWExoMXRuQ2xYM3RPc2RDVnQ5R3pBbzFnVFdwOHA3ckNsbE94SmxuUktLSkpYTkgyVnNmVGRhU2lYc2VINWNwNzBQWUdLNzJ4QWplSWNyU2hqX3VCUzRGcXk2UFdtMHhXeXdSRHlIOVphOHowcVp0VEpMSlF3cnpsV2E2RmpfQldWRzg3ZnhTdjZPcDBEM1EyQi1LaTdleENMWGJqN3lKNENVZzJkZFg2X2NFYUFpMkh0QmgxNGpUem1qanpqbDRqSjR4NnlZT1lUNkFjbW11MjZxT2dZag?oc=5","date":"2024-04-27","type":"deal","source":"Tucson Local Media","summary":"Roche buys large vacant facility in Oro Valley - Tucson Local Media","headline":"Roche buys large vacant facility in Oro Valley","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWHJXRzI1UGZTZ2owRnVuT2JzYzR5RWFZTDZ3SkRXTTBOMjI3UExwbXVyY0p5S3owdG9mWExSS2czT0lScXZtUE9URmFHbE9jWlFZdkRzYjctTzlhTV9BZFhIbkVRYTlPV3pkZXdtQzhVNURhRXBoRy02WF9TNG1lWV9SdWRKRGR2eU5YZ29YNExDUFFxeHE2YUhvUWUxaGFZOVI5Y093d2RKanM?oc=5","date":"2020-06-01","type":"deal","source":"The Business Journals","summary":"Durham firm lands potential $274 million deal with pharma giant - The Business Journals","headline":"Durham firm lands potential $274 million deal with pharma giant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxQNWdBYlhxX0ViaEdraDY5T3hoOFE1b2E0dUJILTZFc0RvZndOWnFDRjJwSTJtS0hYTXJoOHgxR2JnclFrYXhDb3hpclg3cXZPUENDUU01WnVvZUg1V3IxR0Nyb19yNS1aTHVsNTRnb3FZVEZaVlJjcTJHV3RKQXFOdTFMbG13YXlZcl9aN3lpUGVfYU5MQjdtT1E2UTJCUHlTZG8tYnZJQ1hhUlc2VDIwTHVKNHFoYXpMQ2RoOHFzaEpnR0xuYXprWjJnZVZ2OW1RNUtkOEpKM0JoTFR1Rl9LdnZwTUN6T0pMY094Y19sRFUzWi0wSEZyYzRmNFZOTHJGSU4wOHFySWF3SVRoR3ZkR2hR?oc=5","date":"2020-05-29","type":"deal","source":"Business Wire","summary":"Ligand Announces Icagen’s Expansion of Collaboration with Roche to Develop and Commercialize Therapies for Neurological Diseases - Business Wire","headline":"Ligand Announces Icagen’s Expansion of Collaboration with Roche to Develop and Commercialize Therapies for Neurological ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxQTHJoWk43N1U2SVp1UTBlT3o3UU5lWGRLWXRVTnFPd0VzajFSbWs4Z2dMWUdYc25SUjdoQ29tYXhmUHpoRUduNGpLajlFSHh2cV81emxlclU2WVl0SEF4Y1lEbi1Sa1hXbmFzTUtJQ3ZlTVNhSi1pMlpVem0zeVBUaWd4WFowbG1DS3ZYNjNmZDdab0VvOVRnSUNSWVZsVU1MVy1NMUpySDJWRlVTQ2RYWl9DMUxWVGVRemsxNFAyOG1QSWR4dVVYLVhNenRjSUM5bGk4SERtREs4ZnhnbWRtM25fMjk0bzQ2enpJ?oc=5","date":"2020-04-02","type":"deal","source":"Business Wire","summary":"Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs and Ion Channel Technologies - Business Wire","headline":"Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs and Ion Channel Technologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQRWEyUXpQeEh4RHU0RUhOMU1TM3RBaUdySGxJR1U4aGtlZDZaQWhZMnRJbzlpWUJsRGJad3ZZQ1NaUk1LaENwZnBKcTBYQXVBSnNpYVdZeFMxdmRpUmhodmtvTk94M0JiMFBYT2tvYnpyVmRiVlJtNWthbE9BLUE2eVBDZXJCeHZqRWk0Tzdn?oc=5","date":"2020-02-12","type":"deal","source":"Fierce Biotech","summary":"Ligand snags Roche-partnered drug in Icagen buyout - Fierce Biotech","headline":"Ligand snags Roche-partnered drug in Icagen buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPN2lKalBRVkc4djF6Q1pHb0U2UlpkZ2NlZHQyS3VyV2dIeGkwbk1mQXFud0lyaFpHZ0tmbExETzlmVzB0RzR3RXc4czlmS3lVU2RrS291Y0oyVE5QMFRRekJvVnVKUnRoOF9wcnZVWXFNbGtxZDNTLTFuc3BudW5RdjgxRWN4U0xOZlA4b19pLVpTc2ZES1p6WktKTHRfWlh6?oc=5","date":"2017-03-28","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Bayer, Icagen Partner on X-Ray Fluorescence Assays - Genetic Engineering and Biotechnology News","headline":"Bayer, Icagen Partner on X-Ray Fluorescence Assays","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQNFpoM0g2ZHByS3M2dGJTM2dVWTVmVEYwMEhSelJNOEN5SVJVemZVWWMtNUl6SDVQZ2d0OWhTNGxoajl0TGtwcURXV09HNHZIUjJSMFVDdWw0Q3BpRjhVSUhVX0FmMG90REduXzRQT1hjNmNsSUtQQUtBQWVmVzlvODloOWYzajZhZlBtVXBabkFLazJVMVk0OXM2N1pTUVZVMXVBTnM4UllxS3FraVJwQjZXb092NVBfTlRWLVQ4UmhRZ1kt?oc=5","date":"2015-07-04","type":"pipeline","source":"Fierce Pharma","summary":"Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D - Fierce Pharma","headline":"Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}